News

NEWS FROM NOXILIZER | MAY 2023

Special Opportunity to Evaluate the Leading Alternative Sterilization Method for Medical Devices — Nitrogen Dioxide (NO2) Gas Many companies have a corporate initiative underway to evaluate alternative sterilization methods. Noxiizer has been working with a number of global medical device companies to test their current products, as well as new materials for products in development. […]

NEWS FROM NOXILIZER | MAY 2023 Read More »

SPECIAL FEATURE — Noxilizer’s NO₂ sterilization is featured as one of the ways to improve parenteral drug delivery, including prefilled syringes

Elon Musk just warned the world that Artificial Intelligence (AI) is dangerous and has the potential to destroy civi­lization. Yet, AI will likely be used in nearly every industry, and the biopharma industry is no exception. A new report from VisionGain1 shows that 75% of pharmaceutical organizations want to use automated solutions more frequently, driven by

SPECIAL FEATURE — Noxilizer’s NO₂ sterilization is featured as one of the ways to improve parenteral drug delivery, including prefilled syringes Read More »

PRESS RELEASE — Noxilizer NO₂ sterilization used by global pharma and biotech companies on products submitted for regulatory approval

Noxilizer announces that multiple pharmaceutical and biotech companies have completed or are in the process of completing sterilization validation of products that will be submitted to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) starting in early 2023. This marks further advancement in the adoption of nitrogen dioxide (NO₂) sterilization. NO₂ sterilization is rapidly becoming

PRESS RELEASE — Noxilizer NO₂ sterilization used by global pharma and biotech companies on products submitted for regulatory approval Read More »

Scroll to Top